Tizanidine Hydrochloride Capsule
Product Images NDC 80425-0474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 80425-0474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Tizanidine HCl 4mg #30 (Tizanidine HCl 4mg 80425 0474 01)

Tizanidine HCl 4mg #30 (Tizanidine HCl 4mg 80425 0474 01)
Packaging label for Tizanidine Hydrochloride 4 mg capsules, #30 count, labeled by Advanced Rx of Tennessee, LLC. The label includes NDC 80425-0474-01 and displays storage instructions, barcode, and caution about federal law restricting transfer. Manufacturer information shows Advagen Pharma with serial number listed.*
FDA Label Image

Tizanidine HCl 4mg #60 (Tizanidine HCl 4mg 80425 0474 02)

Tizanidine HCl 4mg #60 (Tizanidine HCl 4mg 80425 0474 02)
Packaging label for Tizanidine HCl 4 mg capsules by AdvancedRx of Tennessee, LLC. The label includes the proprietary and generic names, strength, dosage form, quantity (#60), NDC 80425-0474-02, storage instructions at 20°-25°C (68°-77°F), and lot and expiration dates.*
FDA Label Image

Tizanidine HCl 4mg #90 (Tizanidine HCl 4mg 80425 0474 03)

Tizanidine HCl 4mg #90 (Tizanidine HCl 4mg 80425 0474 03)
Label for tizanidine hydrochloride 4 mg capsule by Advanced Rx of Tennessee, LLC, packaged in Nashville, TN. The label includes NDC 80425-0474-03, compares to Zanaflex, and notes lot and expiration information. The label also features storage temperature instructions and a barcode.*
FDA Label Image

Figure 1 (Tizanidine Hydrochloride Capsules Figure 1)

Figure 1 (Tizanidine Hydrochloride Capsules Figure 1)
A line graph showing plasma tizanidine concentration (ng/mL) over 24 hours post dosing. It compares 4 mg tizanidine tablets and capsules, each taken with and without food. The graph illustrates the concentration-time profile for each condition with distinct symbols and lines.*
FDA Label Image

Figure 2 (Tizanidine Hydrochloride Capsules Figure 2)

Figure 2 (Tizanidine Hydrochloride Capsules Figure 2)
Line graph showing improvement in Ashworth Score over time post-dose (0 to 6 hours) for tizanidine hydrochloride 16 mg, 8 mg, and placebo. The 16 mg dose shows the greatest improvement, followed by the 8 mg dose, with placebo showing minimal change.*
FDA Label Image

Figure 3 (Tizanidine Hydrochloride Capsules Figure 3)

Figure 3 (Tizanidine Hydrochloride Capsules Figure 3)
A line plot showing improvement in Ashworth Score over time at three study points: end of titration (Week 3), end of maintenance (Week 7), and endpoint (last observation carried forward). Data is compared for tizanidine (mean dose 28.8 mg) and placebo groups, each with error bars indicating variability.*
FDA Label Image

Chemical Structural Formula (Tizanidine Hydrochloride Capsules Structure)

Chemical Structural Formula (Tizanidine Hydrochloride Capsules Structure)
Chemical structure of tizanidine hydrochloride, showing its molecular arrangement including chloro, thiazole, and imidazoline rings with the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.